UZH-Logo

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)


Heinrich, S; Pestalozzi, B; Lesurtel, M; Berrevoet, F; Laurent, S; Delpero, J R; Raoul, J L; Bachellier, P; Dufour, P; Moehler, M; Weber, A; Lang, H; Rogiers, X; Clavien, P A (2011). Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC Cancer, 11:346.

Citations

23 citations in Web of Science®
30 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

33 downloads since deposited on 19 Oct 2011
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Visceral and Transplantation Surgery
Dewey Decimal Classification:610 Medicine & health
Language:German
Date:2011
Deposited On:19 Oct 2011 11:19
Last Modified:05 Apr 2016 15:02
Publisher:BioMed Central
ISSN:1471-2407
Funders:Swiss National Foundation, Sasella Foundation, Stiftung zur Krebsbekämpfung Zürich, Sanofi-Aventis, TEVA Pharma
Publisher DOI:10.1186/1471-2407-11-346
PubMed ID:21831266
Permanent URL: http://doi.org/10.5167/uzh-49953

Download

[img]
Preview
Content: Published Version
Filetype: PDF
Size: 788kB
View at publisher

Author Collaborations